Oxidative stress and total antioxidant status in myocardial infarction

Singapore Medical Journal

Volumn 48, Issue 2, 2007, Pages 137-142

  Surekha, R H ^a   Srikanth, B B M V ^a   Jharna, P ^a   Ramachandra, R V ^a   Dayasagar, R V ^b   Jyothy, A ^a  

^a OSMANIA UNIVERSITY   (India)

^b Durga Bai Deshmukh Hospital and Research Centre   (India)

Author keywords

Lipid peroxidation; Lipid profiles; Myocardial infarction; Oxidative stress; Total antioxidant status

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CHOLESTEROL; FREE RADICAL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRATE; NITRITE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; NITRIC OXIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EARLY INTERVENTION; ENVIRONMENTAL FACTOR; FEMALE; HEART INFARCTION; HEREDITY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; RISK FACTOR; SMOKING HABIT; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PHYSIOLOGY;

CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 34447550415     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Rauch U, Osende J, Fuster V, et al. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 2001; 134:224-38.
2. Chesebro JH, Rauch U, Fuster V, Badimon JJ. Pathogenesis of thrombosis in coronary artery disease. Haemostasis 1997; 27 suppl 1:12-8.
3. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344:793-5.
4. Comment in: Lancet 1994; 344:1363-4.
5. Betteridge DJ. What is oxidative stress? Metabolism 2000; 49:3-8.
6. Pandya DP. Oxidant injury in coronary heart disease (Part-I): Compr Ther 2001; 27:284-92.
7. Leeuwenburg C, Hardy MM, Hazen SL, et al. Reactive nitrogen intermidiates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997; 272:1433-6.
8. Pinzani P, Petruzzi E, Orlando C, et al. Serum antioxidant capacity in healthy and diabetic subjects as determined by enhanced chemiluminiscence. J Biolumin Chemilumin 1998; 13:321-5.
9. Gavino VC, Miller JS, Ikharebha SO, Milo GE, Cornwell DG. Effects of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J Lipid Res 1981; 22:763-9.
10. Lepoivre M, Chenais B, Yapo A, et al. Alterations of ribonucleotide reductase activity following induction of nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 1990; 265:14143-9.
11. Re R, Pellegrini N, Proteggente A, et al. Antioxidant activity applying an improved ABTS radical cation decolourization assay. Free Radic Biol Med 1999; 26:1231-7.
12. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease - the Framingham Heart Study. Can J Cardiol 1988; 4 suppl A:5A-10A.
13. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79:8-15.
14. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325:373-81.
15. Comment in: N Engl J Med 1992;326:490-1;discussion 491-2.
16. Rajmohan L, Deepa R, Mohan V. Risk factors for coronary artery disease in Indians: emerging trends. Indian Heart J 2000; 52:221-5.
17. Mackness MI, Abbott C, Arrol S, Durrington PN. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 1993; 294:829-34.
18. McKeique PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 1989; 42:597-601.
19. Gopinath N, Chadha SL, Sehgal A, Shekhawat S, Tandon R. What is 'desirable' lipid profile. Indian Heart J 1994; 46:325-7.
20. Gupta R, Kaul V, Prakash H, et al. Lipid abnormalities in coronary heart disease: a population-based case-control study. Indian Heart J 2001; 53:332-6.
21. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003: 91:12A-16A.
22. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 40:115-26.
23. Comment in: N Engl J Med 1999; 340:1928-9.
24. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis 1988; 8:348-58.
25. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr 1985; 5:365-90.
26. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990; 186:421-31.
27. Holvoet P. Oxidative modification of low-density lipoproteins in atherothrombosis. Acta Cardiol 1998; 53:253-60.
28. Holvoet P, Perez G, Zhao Z, et al. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest 1995; 95:2611-9.
29. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57 (5 suppl):715S-725S.
30. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13:341-90.
31. Cavalca V, Cighetti G, Bamonti F, et al .Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47:887-92.
32. Tamer L, Sucu N, Polat G, et al. Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. Arch Med Res 2002: 33:257-60. Erratum in: Arch Med Res 2002; 33:513.
33. Ledwozyw A, Michalak J, Stepien A, Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986; 155:275-83.
34. Jain AP, Mohan A, Gupta OP, et al. Role of oxygen free radicals in causing endothelial damage in acute myocardial infarction. J Assoc Physicians India 2000; 48:478-80.
35. Berg K, Jynge P, Bjerve K, et al. Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction. Free Radic Res 2005; 39:629-36.
36. Humphries SE, Talmud PJ, Hawe E, et al. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001; 358:115-9.
37. Comment in: Lancet 2001; 358:87-8.
38. Lancet 2003; 361:1909; author reply 1909-10.
39. Winkelmann BR, Boehm BO, Nauck M, et al. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Cur Med Res Opin 2001; 17:132-41.
40. Corella D, Tucker K, Lahoz C, et al. Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 2001; 73:736-45.
41. Comment in: Am J Clin Nutr 2001; 73:669-70.
42. Saxena KK. Congestive heart failure in diabetes. Cardiol Today 2002; 6:71-6.
43. Fazendas P, Joao IF, Llobet S, et al. [Plasma total anti-oxidant status in young survivors of myocardial infarction]. Rev Port Cardiol 2000; 19:463-7. Portuguese.
44. Nojiri S, Daida H, Mokuno H, et al. Association of serum antioxidant capacity with coronary artery disease in middle-aged men Jpn Heart J 2001; 42:677-90.
45. Berg K, Wiseth R, Bjerve K, et al. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 2004; 38:517-25.
46. Bhoraskar A. Nutritional factors and their role in diabetes. J Diab Assoc India 2002; 42:3-7.
47. Gasparetto C, Malinverno A, Culacciati D, et al. Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction. Int J Immunopathol Pharmacol 2005; 18:487-96.
48. Gupta R, Deedwania PC, Soangra MR. Prevention of coronary heart disease in India: an epidemiological perspective. Ind J Commun Med 2002; 27:185-90.